Mindfulness instruction for medication adherence among adolescents and young adults living with HIV: a randomized controlled trial.
AIDS Care December 2022 Erica Sibinga, Lindsey Webb, Jamie Perin et al.
Adolescents and young adults (AYA) 13-24 years old make up a disproportionate 21% of new HIV diagnoses. Unfortunately, they are less likely to treat HIV effectively, with only 30% achieving viral suppression, limiting efforts to interrupt HIV transmission. Previous work with mindfulness-based stress reduction (MBSR) has shown promise for improving treatment in AYA living with HIV (AYALH). This...